INVOKANA 100 mg/1
canagliflozin · TABLET, FILM COATED · Cardinal Health 107, LLC
No Recall History
Plain English
INVOKANA is a tablet, film coated containing canagliflozin at 100 mg/1, taken oral. Manufactured by Cardinal Health 107, LLC.
Key Facts
- Brand Name
- INVOKANA
- Generic Name
- canagliflozin
- NDC Code (Product)
55154-1425- Manufacturer
- Cardinal Health 107, LLC
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA204042
- Marketing Start
- 03/29/2013
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
diabetic ketoacidosis3,423 reports
toe amputation2,195 reports
osteomyelitis2,165 reports
acute kidney injury1,994 reports
fungal infection1,447 reports
weight decreased1,341 reports
blood glucose increased1,232 reports
gangrene1,084 reports
cellulitis1,035 reports
urinary tract infection1,018 reports
Frequently Asked Questions
What is INVOKANA used for?
INVOKANA contains canagliflozin. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is INVOKANA a controlled substance?
INVOKANA is not classified as a controlled substance by the DEA.
What is the generic name for INVOKANA?
The generic name for INVOKANA is canagliflozin. There are 7 other brand versions of canagliflozin.
What is the NDC code for INVOKANA 100 mg/1?
The NDC (National Drug Code) for INVOKANA 100 mg/1 is 55154-1425, listed by Cardinal Health 107, LLC.